|
1
|
Friedman DS, O’Colmain BJ, Munoz B, Tomany
SC, McCarty C, de Jong PT, Nemesure B, Mitchell P and Kempen J; Eye
Diseases Prevalence Research Group. Prevalence of age-related
macular degeneration in the United States. Arch Ophthalmol.
122:564–572. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Klaver CC, Wolfs RC, Vingerling JR, Ofman
A and De Jong PT: Age specific prevalence and causes of blindness
and visual impairment in an older population: the Rotterdam Study.
Arch Ophthalmol. 116:653–658. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fine SL, Berger JW, Maguire MG and Ho AC:
Age-related macular degeneration. N Engl J Med. 342:483–492. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McConnell V and Silvestri G: Age-related
macular degeneration. Ulster Med J. 74:82–92. 2005.PubMed/NCBI
|
|
5
|
Nowak JZ: Role of lipofuscin in
pathogenesis of age-related macular degeneration (AMD). Mag Okul.
2:103–114. 2005.(In Polish).
|
|
6
|
Nowak JZ: Drusen, basal deposits,
inflammation and age-related macular degeneration (AMD). Mag Okul.
2:174–186. 2005.(In Polish).
|
|
7
|
Bird AC, Bressler NM, Bressler SB,
Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE,
Klein R, et al: An international classification and grading system
for age-related maculopathy and age-related macular degeneration.
The International ARM Epidemiological Study Group. Surv Ophthalmol.
39:367–374. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Anderson DH, Mullins RF, Hageman GS and
Johnson LV: A role for local inflammation in the formation of
drusen in the aging eye. Am J Ophthalmol. 134:411–431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Campochiaro PA: Ocular neovascularization
and excessive vascular permeability. Expert Opin Biol Ther.
4:1395–1402. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kijlstra A, La Heij EC and Hendrikse F:
Immunological factors in the pathogenesis and treatment of
age-related macular degeneration. Ocular Immunol Inflam. 13:3–11.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Klein R, Peto T, Bird A and Vannewkirk MR:
The epidemiology of age-related macular degeneration. Am J
Ophthalmol. 137:486–495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sparrow JR and Boulton M: RPE lipofuscin
and its role in retinal pathobiology. Exp Eye Res. 80:595–606.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wiktorowska-Owczarek A and Nowak JZ:
Oxidative damage in age-related macular degeneration (AMD) and
antioxidant protection as a therapeutic strategy. Pol J Environ
Stud. 15:69–72. 2006.
|
|
14
|
Beatty S, Koh H, Phil M, Henson D and
Boulton M: The role of oxidative stress in the pathogenesis of
age-related macular degeneration. Surv Ophthalmol. 45:115–134.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dunaief JL, Dentchev T, Ying GS and Milam
AH: The role of apoptosis in age-related macular degeneration. Arch
Ophthalmol. 120:1435–1442. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Winkler BS, Boulton ME, Gottsch JD and
Sternberg P: Oxidative damage and age-related macular degeneration.
Mol Vis. 5:321999.PubMed/NCBI
|
|
17
|
Hollyfield JG, Salomon RG and Crabb JW:
Proteomic approaches to understanding age-related macular
degeneration. Adv Exp Med Biol. 533:83–89. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jin GF, Hurst JS and Godley BF: Rod outer
segments mediate mitochondrial DNA damage and apoptosis in human
retinal pigment epithelium. Curr Eye Res. 23:11–19. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wolf G: Lipofuscin and macular
degeneration. Nutr Rev. 61:342–346. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shamsi FA and Boulton M: Inhibition of the
RPE lysosomal and antioxidant activity by the age pigment
lipofuscin. Invest Ophthalmol Vis Sci. 42:3041–3046.
2001.PubMed/NCBI
|
|
21
|
Sundelin S, Wihlmark U, Nilsson SE and
Brunk UT: Lipofuscin accumulation in cultured retinal pigment
epithelial cells reduces their phagocytic capacity. Curr Eye Res.
17:851–857. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rakoczy PE, Zhang D, Robertson T, Barnett
NL, Papadimitriou J, Constable IJ and Lai CM: Progressive
age-related changes similar to age-related macular degeneration in
a transgenic mouse model. Am J Pathol. 161:1515–1524. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shaban H, Borras C, Vina J and Richter C:
Phosphatidylglycerol potently protects human retinal pigment
epithelial cells against apoptosis induced by A2E, a compound
suspected to cause age-related macula degeneration. Exp Eye Res.
75:99–108. 2002. View Article : Google Scholar
|
|
24
|
Suter M, Remé C, Grimm C, Wenzel A,
Jaattela M, Esser P, Kociok N, Leist M and Richter C: Age-related
macular degeneration. The lipofusion component
N-retinyl-N-retinylidene ethanolamine detaches proapoptotic
proteins from mitochondria and induces apoptosis in mammalian
retinal pigment epithelial cells. J Biol Chem. 275:39625–39630.
2000. View Article : Google Scholar
|
|
25
|
Kroemer G and Reed JC: Mitochondrial
control of cell death. Nat Med. 6:513–519. 2000. View Article : Google Scholar
|
|
26
|
Schon EA and Manfredi G: Neuronal
degeneration and mitochondrial dysfunction. J Clin Invest.
111:303–312. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
James AM and Murphy MP: How mitochondrial
damage affects cell function. J Biomed Sci. 9:475–487. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Toescu EC, Myronova N and Verkhratsky A:
Age-related structural and functional changes of brain
mitochondria. Cell Calcium. 28:329–338. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Paradies G, Ruggiero FM, Petrosillo G and
Quagliariello E: Age-dependent decline in the cytochrome c
oxidase activity in rat heart mitochondria: role of cardiolipin.
FEBS Lett. 406:136–138. 1997.PubMed/NCBI
|
|
30
|
Crompton M: Mitochondria and aging: a role
for the permeability transition. Aging Cell. 3:3–6. 2004.
View Article : Google Scholar
|
|
31
|
Gabbita SP, Subramaniam R, Allouch F,
Carney JM and Butterfield DA: Effects of mitochondrial respiratory
stimulation on membrane lipids and proteins: an electron
paramagnetic resonance investigation. Biochim Biophys Acta.
1372:163–173. 1998. View Article : Google Scholar
|
|
32
|
Rottenberg H and Wu S: Mitochondrial
dysfunction in lymphocytes from old mice: enhanced activation of
the permeability transition. Biochem Biophys Res Commun. 240:68–74.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sugrue MM and Tatton WG: Mitochondrial
membrane potential in aging cells. Biol Signals Recept. 10:176–188.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Battelli D, Bellei M, Arrigoni-Martelli E,
Muscatello U and Bobyleva V: Interaction of carnitine with
mitochondrial cardiolipin. Biochim Biophys Acta. 1117:33–36. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zammit VA, Corstorphine CG, Kolodziej MP
and Fraser F: Lipid molecular order in liver mitochondrial outer
membranes, and sensitivity of carnitine palmitoyltransferase I to
malonyl-CoA. Lipids. 33:371–376. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Beaumont K, Skowronski R, Vaughn DA and
Fanestil DD: Interactions of lipids with peripheral-type
benzodiazepine receptors. Biochem Pharmacol. 37:1009–1014. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Campbell AM, Capuano A and Chan SH: A
cholesterol-binding and transporting protein from rat liver
mitochondria. Biochim Biophys Acta. 1567:123–132. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hansson M, Ellis E, Hunt MC, Schmitz G and
Babiker A: Marked induction of sterol 27-hydroxylase activity and
mRNA levels during differentiation of human cultured monocytes into
macrophages. Biochim Biophys Acta. 1593:283–289. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Papadopoulos V: Peripheral benzodiazepine
receptor: structure and function in health and disease. Ann Pharm
Fr. 61:30–50. 2003.PubMed/NCBI
|
|
40
|
Denton RM, Randle PJ, Bridges BJ, Cooper
RH, Kerbey AL, Pask HT, Severson DL, Stansbie D and Whitehouse S:
Regulation of mammalian pyruvate dehydrogenase. Mol Cell Biochem.
9:27–53. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Robison WG Jr and Kuwabara T:
Microperoxisomes in the retinal pigment epithelium. Invest
Ophthalmol. 14:866–872. 1975.PubMed/NCBI
|
|
42
|
Szabo II, Adams C and Gulbins E: Ion
channels and membrane rafts in apoptosis. Pflugers Arch.
448:304–312. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Beuerman RW and Stern ME: Neurogenic
inflammation: a first line of defense for the ocular surface. Ocul
Surf. 3(Suppl 4): S203–S206. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Troger J, Kieselbach G, Teuchner B,
Kralinger M, Nguyen QA, Haas G, Yayan J, Gottinger W and Schmid E:
Peptidergic nerves in the eye, their source and potential
pathophysiological relevance. Brain Res Rev. 53:39–62.
2007.PubMed/NCBI
|
|
45
|
Stern ME, Gao J, Siemasko KF, Beuerman RW
and Pflugfelder SC: The role of the lacrimal functional unit in the
pathophysiology of dry eye. Exp Eye Res. 78:409–416. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kovacs I, Ludany A, Koszegi T, Fehér J,
Kovacs B, Szolcsanyi J and Pintér E: Substance P released from
sensory nerve endings influences tear secretion and goblet cell
function in the rat. Neuropeptides. 39:395–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Feher J: Contribution of neurogenic
inflammation to irritable eye syndrome. Adv Exp Med Biol.
506:1047–1050. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Baudouin C: A new approach for better
comprehension of diseases of the ocular surface. J Fr Ophtalmol.
30:239–246. 2007.(In French).
|
|
49
|
Brecha NC, Sternini C, Anderson K and
Krause JE: Expression and cellular localization of substance
P/neurokinin A and neurokinin B mRNAs in the rat retina. Vis
Neurosci. 3:527–535. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Caruso DM, Owczarzak MT and Pourcho RG:
Colocalization of substance P and GABA in retinal ganglion cells: a
computer-assisted visualization. Vis Neurosci. 5:389–394. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bagnoli P, Dal Monte M and Casini G:
Expression of neuropeptides and their receptors in the developing
retina of mammals. Histol Histopathol. 18:1219–1242.
2003.PubMed/NCBI
|
|
52
|
May A, Shepheard SL, Knorr M, Effert R,
Wessing A, Hargreaves RJ, Goadsby PJ and Diener HC: Retinal plasma
extravasation in animals but not in humans: implications for the
pathophysiology of migraine. Brain. 121:1231–1237. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gaspar MN, Ribeiro CA, Cunha-Vaz JG and
Macedo TR: Effects of neuropeptides on the sumatriptan-disturbed
circulation in the optic nerve head of rabbits. Pharmacology.
70:152–159. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nucci C, Gasperi V, Tartaglione R, Cerulli
A, Terrinoni A, Bari M, De Simone C, Agrò AF, Morrone LA,
Corasaniti MT, Bagetta G and Maccarrone M: Involvement of the
endocannabinoid system in retinal damage after high intraocular
pressure-induced ischemia in rats. Invest Ophthalmol Vis Sci.
48:2997–3004. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bronzetti E, Artico M, Kovacs I, Felici
LM, Magliulo G, Vignone D, D’Ambrosio A, Forte F, Di Liddo R and
Feher J: Expression of neurotransmitters and neurotrophins in
neurogenic inflammation of the rat retina. Eur J Histochem.
51:251–260. 2007.PubMed/NCBI
|
|
56
|
Szolcsanyi J: Forty years in capsaicin
research for sensory pharmacology and physiology. Neuropeptide.
38:377–384. 2004.PubMed/NCBI
|
|
57
|
Fujita S, Shimizu T, Izumi K, Fukuda T,
Sameshima M and Ohba N: Capsaicin-induced neuroparalytic
keratitis-like corneal changes in the mouse. Exp Eye Res.
38:165–175. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ogilvy CS, Silverberg KR and Borges LF:
Sprouting of corneal sensory fibers in rats treated at birth with
capsaicin. Invest Ophthalmol Vis Sci. 32:112–121. 1991.PubMed/NCBI
|
|
59
|
Gallar J, Pozo MA, Rebollo I and Belmonte
C: Effects of capsaicin on corneal wound healing. Invest Ophthalmol
Vis Sci. 31:1968–1974. 1990.PubMed/NCBI
|
|
60
|
Waldrep JC and Crosson CE: Induction of
keratouveitis by capsaicin. Curr Eye Res. 7:1173–1182. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ritter S and Dinh TT: Capsaicin-induced
neuronal degeneration in the brain and retina of preweanling rats.
J Comp Neurol. 296:447–461. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tombran-Tink J, Shivaram SM, Chader GJ,
Johnson LV and Bok D: Expression, secretion, and age-related
downregulation of pigment epithelium-derived factor, a serpin with
neurotrophic activity. J Neurosci. 15:4992–5003. 1995.PubMed/NCBI
|
|
63
|
Becerra SP, Palmer I, Kumar A, Steele F,
Shiloach J, Notario V and Chader GJ: Overexpression of fetal human
pigment epithelium-derived factor in Escherichia coli: a
functionally active neurotrophic factor. J Biol Chem.
268:23148–23156. 1993.PubMed/NCBI
|
|
64
|
Dawson DW, Volpert OV, Gillis P, Crawford
SE, Xu H, Benedict W and Bouck NP: Pigment epithelium-derived
factor: a potent inhibitor of angiogenesis. Science. 285:245–258.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Chung C, Doll JA, Stellmach VM, Gonzales
J, Surapureddi S, Cornwell M, Reddy JK and Crawford SE: Pigment
epithelium-derived factor is an angiogenesis and lipid regulator
that activates peroxisome proliferator-activated receptor alpha.
Adv Exp Med Biol. 617:591–597. 2008. View Article : Google Scholar
|
|
66
|
Bouck N: PEDF: anti-angiogenic guardian of
ocular function. Trends Mol Med. 8:330–334. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Spranger J, Osterhoff M, Reimann M, Mohlig
M, Ristow M, Francis MK, Cristofalo V, Hammes HP, Shith G, Boulton
M and Pfeiffer AF: Loss of the antiangiogenic pigment
epithelium-derived factor in patients with angiogenic eye disease.
Diabetes. 50:2641–2645. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zingsheim HP and Plattner H: Electron
microscopic methods in membrane biology. Methods in Membrane
Biology. Korn ED: Plenum Press; New York, NY: 1. –146. 1976,
View Article : Google Scholar
|
|
69
|
Hirai K, Aliev G, Nunomura A, Fujioka H,
Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M,
Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB,
Perry G and Smith MA: Mitochondrial abnormalities in Alzheimer’s
disease. J Neurosci. 21:3017–3023. 2001.
|
|
70
|
Kelley DE, He J, Menshikova EV and Ritov
VB: Dysfunction of mitochondria in human skeletal muscle in type 2
diabetes. Diabetes. 51:2944–2950. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gosker HR, Wouters EFM, van der Vusse GJ
and Schols AMWJ: Skeletal muscle dysfunction in chronic obstructive
pulmonary disease and chronic heart failure: underlying mechanisms
and therapy perspectives. Am J Clin Nutr. 71:1033–1047.
2000.PubMed/NCBI
|
|
72
|
Ben-Shachar D: Mitochondrial dysfunction
in schizophrenia: a possible linkage to dopamine. J Neurochem.
83:1241–1251. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Fox DA, Poblenz AT, He L, Harris JB and
Medrano CJ: Pharmacological strategies to block rod photoreceptor
apoptosis caused by calcium overload: a mechanistic target-site
approach to neuroprotection. Eur J Ophthalmol. 13(Suppl 3):
S44–S56. 2003.PubMed/NCBI
|
|
74
|
Tyni T, Johnson M, Eaton S, Pourfarzam M,
Andrews R and Turnbull DM: Mitochondrial fatty acid beta-oxidation
in the retinal pigment epithelium. Pediatr Res. 52:595–600.
2002.PubMed/NCBI
|
|
75
|
Andrews RM, Griffiths PG, Johnson MA and
Turnbull DM: Histochemical localisation of mitochondrial enzyme
activity in human optic nerve and retina. Br J Ophthalmol.
83:231–235. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Hiltunen JK and Qin Y:
Beta-oxidation-strategies for the metabolism of a wide variety of
acyl-CoA esters. Biochem Biophys Acta. 1484:117–128.
2000.PubMed/NCBI
|
|
77
|
Kuksa V, Imanishi Y, Batten M, Palczewski
K and Moise AR: Retinoid cycle in the vertebrate retina:
experimental approaches and mechanisms of isomerization. Vision
Res. 43:2959–2981. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Sparrow JR, Fishkin N, Zhou J, Cai B, Jang
YP, Krane S, Itagaki Y and Nakanishi K: A2E, a byproduct of the
visual cycle. Vision Res. 43:2983–2990. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Sprecher H: Metabolism of highly
unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta.
1486:219–231. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Hettema EH and Tabak HF: Transport of
fatty acids and metabolites across the peroxisomal membrane.
Biochim Biophys Acta. 1486:18–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Kliewer SA, Sundseth SS, Jones SA, Brown
PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Wilson TM, Lenhard JM
and Lehmann JM: Fatty acids and eicosanoids regulate gene
expression through direct interactions with peroxisome
proliferator-activated receptors alpha and gamma. Proc Natl Acad
Sci USA. 94:4318–4323. 1997. View Article : Google Scholar
|
|
82
|
Kersten S, Desvergne B and Wahli W: Roles
of PPARs in health and disease. Nature. 405:421–424. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Nagy L, Tontonoz P, Alvarez JGA, Chen H
and Evans RM: Oxidized LDL regulates macrophage gene expression
through ligand activation of PPARgamma. Cell. 93:229–240. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Murata T, He S, Hangai M, Ishibashi T, Xi
XP, Kim S, Hsueh WA, Ryan SJ, Law RE and Hinton DR: Peroxisome
proliferator-activated receptor-gamma ligands inhibit choroidal
neovascularization. Invest Ophthalmol Vis Sci. 41:2309–2317.
2000.PubMed/NCBI
|
|
85
|
Forman BM, Chen J and Evans RM:
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids
are ligands for peroxisome proliferator-activated receptors alpha
and delta. Proc Natl Acad Sci USA. 94:4312–4317. 1997. View Article : Google Scholar
|
|
86
|
Keller H, Dreyer C, Medin J, Mahfoudi A,
Ozato K and Wahli W: Fatty acids and retinoids control lipid
metabolism through activation of peroxisome proliferator-activated
receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA.
90:2160–2164. 1993. View Article : Google Scholar
|
|
87
|
Brunk UT and Terman A: The
mitochondrial-lysosomal axis theory of aging: accumulation of
damaged mitochondria as a result of imperfect autophagocytosis. Eur
J Biochem. 269:1996–2002. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Katz ML, Rice LM and Gao CL: Reversible
accumulation of lipofuscin-like inclusions in the retinal pigment
epithelium. Invest Ophthalmol Vis Sci. 40:175–181. 1999.PubMed/NCBI
|
|
89
|
Von Ruckmann A, Schmidt KG, Fitzke FW,
Bird AC and Jacobi KW: Dynamics of accumulation and degradation of
lipofuscin in retinal pigment epithelium in senile macular
degeneration. Klin Monbl Augenheilkd. 213:32–37. 1998.(In
German).
|
|
90
|
Kennedy CJ, Rakoczy PE and Constable IJ:
Lipofuscin of the retinal pigment epithelium: a review. Eye (Lond).
9:763–771. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Marmorstein AD, Marmorstein LY, Sakaguchi
H and Hollyfield JG: Spectral profiling of autofluorescence
associated with lipofuscin, Bruch’s membrane, and sub-RPE deposits
in normal and AMD eyes. Invest Ophthalmol Vis Sci. 43:2435–2441.
2002.PubMed/NCBI
|
|
92
|
Feher J, Kovacs I, Artico M, Cavallotti C,
Papale A and Balacco Gabrieli C: Mitochondrial aterations of
retinal pigment epithelium in age-related macular degeneration.
Neurobiol Aging. 27:983–993. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Furuno T, Kanno T, Arita K, Asami M,
Utsumi T, Doi Y, Inoue M and Utsumi K: Roles of long chain fatty
acids and carnitine in mitochondrial membrane permeability
transition. Biochem Pharmacol. 62:1037–1046. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Pepe S: Mitochondrial function in
ischaemia and reperfusion of the ageing heart. Clin Exp Pharmacol
Physiol. 27:745–750. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Gunthorpe MJ and Szallasi A: Peripheral
TRPV1 receptors as targets for drug development: new molecules and
mechanisms. Curr Pharm Des. 14:32–41. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Lázár J, Szabó T, Marincsák R, Kovács L,
Blumberg PM and Bíró T: Sensitization of recombinant vanilloid
receptor-1 by various neurotrophic factors. Life Sci. 75:153–163.
2004.PubMed/NCBI
|
|
97
|
Aloe L, Tirassa P and Lambiase A: The
topical application of nerve growth factor as a pharmacological
tool for human corneal and skin ulcers. Pharmacol Res. 57:253–258.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Feher J, Kovacs I, Pacella E, Keresz S,
Spagnardi N and Balacco Gabrieli C: Pigment epithelium-derived
factor (PEDF) attenuated capsaicin-induced neurotrophic
keratouveitis. Invest Ophthalmol Vis Sci. 50:5173–5180. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Gao G, Li Y, Zhang D, Gee S, Crosson C and
Ma J: Unbalanced expression of VEGF and PEDF in ischemia-induced
retinal neovascularization. FEBS Lett. 489:270–276. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Jin KL, Mao XO and Greenberg DA: Vascular
endothelial growth factor: direct neuroprotective effect in in
vitro ischemia. Proc Natl Acad Sci USA. 97:10242–10247. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zachary I: Neuroprotective role of
vascular endothelial growth factor: signalling mechanisms,
biological function, and therapeutic potential. Neurosignals.
14:207–221. 2005. View Article : Google Scholar
|
|
102
|
Khaibullina AA, Rosenstein JM and Krum JM:
Vascular endothelial growth factor promotes neurite maturation in
primary CNS neuronal cultures. Brain Res Dev Brain Res. 148:59–68.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Feher J, Papale A, Mannino G, Gualdi G and
Balacco Gabrieli C: Mitotropic compounds for the treatment of
age-related macular degeneration. The metabolic approach and a
pilot study. Ophthalmologica. 217:351–357. 2003. View Article : Google Scholar : PubMed/NCBI
|
